121 related articles for article (PubMed ID: 22093558)
1. [The relationship between coagulation/anticoagulation imbalance and oxidative stress in patients with chronic obstructive pulmonary disease].
Huang J; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
Zhonghua Nei Ke Za Zhi; 2011 Aug; 50(8):664-7. PubMed ID: 22093558
[TBL] [Abstract][Full Text] [Related]
2. [Oxidative stress status in patients with chronic obstructive pulmonary disease and its relation to glucocorticoid receptor levels].
Liu LY; Zeng M; Xie CM; Gao JH; Yan YS; Lu GF; Wang H; He YP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):992-6. PubMed ID: 18583246
[TBL] [Abstract][Full Text] [Related]
3. [Change of coagulation functions and its significance in acute exacerbation of chronic obstructive pulmonary disease].
Huang XX; Pang BS; Yang YH; Zhang HY; Guo SL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1543-5. PubMed ID: 21914367
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
[TBL] [Abstract][Full Text] [Related]
5. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
[TBL] [Abstract][Full Text] [Related]
6. [Effects of cigarette smoke on phagocytosed function of monocyte-derived macrophage in chronic obstructive pulmonary disease patients].
Pang Q; Liu X; Shi K; Zeng X; Bao H
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):895-8. PubMed ID: 24854907
[TBL] [Abstract][Full Text] [Related]
7. [Platelet factor 4 and β-thromboglobulin in blood plasma of patients with acute exacerbation of chronic obstructive pulmonary disease].
Wu JF; Yang YH; Pang BS
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1378-82. PubMed ID: 24025501
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of tissue factor and its inhibitor in chronic thromboembolic pulmonary hypertension: a step closer to explanation of the disease aetiology?
Cisowska-Czajka ME; Mazij MP; Kotschy MH; Lewczuk J
Kardiol Pol; 2016; 74(11):1332-1338. PubMed ID: 27221958
[TBL] [Abstract][Full Text] [Related]
9. [Effect of nasal intermittent positive pressure ventilation on N-terminal pro-brain natriuretic peptide in patients with acute exacerbations of chronic obstructive pulmonary disease and type II respiratory failure].
Wang Y; Yang Y; Chen P; Luo Y; Yang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):325-31. PubMed ID: 22561561
[TBL] [Abstract][Full Text] [Related]
10. [A study on oxidative DNA damage and lipid peroxidation in patients with tuberculous pleurisy].
Liu W; Liu XJ; Yu Q; Zhao J; Lei ZL; Li L
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Dec; 26(12):781-4. PubMed ID: 14720436
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
[TBL] [Abstract][Full Text] [Related]
12. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
[TBL] [Abstract][Full Text] [Related]
13. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
14. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods.
Gumral N; Naziroglu M; Ongel K; Beydilli ED; Ozguner F; Sutcu R; Caliskan S; Akkaya A
Cell Biochem Funct; 2009 Jul; 27(5):276-83. PubMed ID: 19475625
[TBL] [Abstract][Full Text] [Related]
16. Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde.
Antus B; Harnasi G; Drozdovszky O; Barta I
Respirology; 2014 Jan; 19(1):74-9. PubMed ID: 23834671
[TBL] [Abstract][Full Text] [Related]
17. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
[TBL] [Abstract][Full Text] [Related]
18. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
[TBL] [Abstract][Full Text] [Related]
19. [Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease].
Chen YH; Yao WZ; Geng B; Ding YL; Lu M; Zhao MW; Tang CS
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):694-7. PubMed ID: 16255955
[TBL] [Abstract][Full Text] [Related]
20. [Changes of tissue factor and tissue factor pathway inhibitor in neonatal jaundice due to infection].
Yue SJ; Zhong L; He XF; Yang YJ; Jiang L; He SL; Li JC
Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):104-6. PubMed ID: 14759309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
